COMPASS Pathways plc
COMP006
treatment-resistant depression (TRD)
Resolved
7days ago
Phase 2 readout · Jun 30, 2026
What's at stake
Phase 2 trial results for COMP006 in treatment-resistant depression (TRD) are due Jun 30, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 17h ago
“26-week (Part B) data from COMP006, expected in early Q3 2026.”